CN104887909A - Application of external-application traditional Chinese medicine for treating arthritis - Google Patents
Application of external-application traditional Chinese medicine for treating arthritis Download PDFInfo
- Publication number
- CN104887909A CN104887909A CN201510265933.8A CN201510265933A CN104887909A CN 104887909 A CN104887909 A CN 104887909A CN 201510265933 A CN201510265933 A CN 201510265933A CN 104887909 A CN104887909 A CN 104887909A
- Authority
- CN
- China
- Prior art keywords
- parts
- rhizoma
- plaster
- chinese medicine
- cortex
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to application of a traditional Chinese medicine preparation in preparation of plaster for treating arthritis. The traditional Chinese medicine preparation is prepared from the following raw pharmaceutical materials in parts by weight: 10-20 parts of heracleum hemsleyanum, 10-20 parts of dandelion, 10-20 parts of herb of common herons bill, 10-20 parts of rhizoma coptidis, 10-20 parts of opuntia dillenii, 10-20 parts of bark of Chinese redbud, 5-10 parts of centipeda, 5-10 parts of phellodendron bark, 5-10 parts of toad, 5-10 parts of rhizoma acori calami, 5-10 parts of mulberry bark, 5-10 parts of corydalis tuber, 10-15 parts of notoperygium root, 10-15 parts of spina gleditsiae, 10-15 parts of aloe, 10-15 parts of cnidium monnieri and 15-20 parts of mulberry twigs. According to the plaster for treating arthritis, disclosed by the invention, the compatibility accords with the principle of the assistant and guide of the traditional Chinese medicine, and the formula is scientific and reasonable; drugs are subjected to transdermal absorption, so that the potency of the drugs can directly act on an affected part during treatment, and tenderness and swelling of joints are rapidly relieved; the plaster has the advantages of high effect taking speed, no toxic or side effects, low cost and the like; and no recurrence occurs after treatment, so that the plaster not only has a satisfactory short-term curative effect, but also has a good long-term curative effect.
Description
Technical field
The present invention relates to the field of Chinese medicines, specifically, is the application of a kind of Chinese medicine preparation in the plaster of preparation treatment of arthritis.
Background technology
Osteoarthritis is a kind of with articular cartilage degeneration, and under cartilage and periarticular have new bone formation, increase the weight of when load-bearing with pain, articular cartilage wearing and tearing and disappearance, hyperosteogeny and cause joint deformity, time movable, there is friction sound in joint, and local tenderness and joint mild swelling are the disease of main manifestations.Primary disease is included in " rheumatism involving the bone " category by motherland's medical science.Think that its morbidity is nothing more than affection of exogenous wind-cold damp, internal injury is in deficiency of the liver and kindey, qi-blood disharmony or have tumbling down damage, and all make QI-blood circulation smooth, channels retardance is obstructed, and sick then both liver and kidney deficiency of a specified duration, muscle cartilage withers, dysfunction.
The clinical manifestation primary disease of osteoarthritis is without General Symptoms, and onset is slow.The earliest and outstanding symptom is that affected joints is ached, when erecting after starting to be mainly in morning and rising or do for a long time, alleviate after movable, hyperactivity pain more again, mostly is dull pain.Have a rest when being in a bad way and also feel pain, even affect sleep.Cold and humidity makes pain increase the weight of.The stiff sense of affected joints is similar to joint aches, often betides when coming into play after rising morning or having a rest, and continues half to one hour, the whistle add movable after stiff sense namely disappear or alleviate.Ankylosis sense is also normal to be increased the weight of with very cold, and late period, due to joint deformity, adds that hyperosteogeny is formed, and can cause joint motion limited.At present, modern medicine does not have good radical cure way yet to osteoarthritis, and treatment exists larger side effect.So motherland's medical science has obvious advantage in the preventing and treating of osteoarthritis, and therefore, a kind of osteoarthritis treatment method of seeking tcm characteristic is desirability.
Summary of the invention
The object of the invention is for deficiency of the prior art, the application of a kind of Chinese medicine preparation in the plaster of preparation treatment of arthritis is provided.
The technical scheme that the present invention takes is the application of a kind of Chinese medicine preparation in the plaster of preparation treatment of arthritis, described Chinese medicine preparation is made up of the crude drug of following weight portion: Radix Angelicae Pubescentis, Herba Taraxaci, geranium, Rhizoma Coptidis, Radix et Caulis Opuntiae Dillenii, each 10-20 part of Cortex cercis chinensis, Herba Centipedae, Cortex Phellodendri, Bufo siccus, Rhizoma Acori Calami, Cortex Mori, each part of Rhizoma Corydalis 5-10, Rhizoma Et Radix Notopterygii, Spina Gleditsiae, Aloe, each 10-15 part of Fructus Cnidii, Ramulus Mori 15-20 part.
Preferably described Chinese medicine preparation is made up of the crude drug of following weight portion: Radix Angelicae Pubescentis, Herba Taraxaci, geranium, Rhizoma Coptidis, Radix et Caulis Opuntiae Dillenii, each 14-16 part of Cortex cercis chinensis, Herba Centipedae, Cortex Phellodendri, Bufo siccus, Rhizoma Acori Calami, Cortex Mori, each 7-9 part of Rhizoma Corydalis, Rhizoma Et Radix Notopterygii, Spina Gleditsiae, Aloe, each 13-16 part of Fructus Cnidii, Ramulus Mori 16-19 part.
Preferably described Chinese medicine preparation is made up of the crude drug of following weight portion: Radix Angelicae Pubescentis, Herba Taraxaci, geranium, Rhizoma Coptidis, Radix et Caulis Opuntiae Dillenii, each 15 parts of Cortex cercis chinensis, Herba Centipedae, Cortex Phellodendri, Bufo siccus, Rhizoma Acori Calami, Cortex Mori, each 8 parts of Rhizoma Corydalis, Rhizoma Et Radix Notopterygii, Spina Gleditsiae, Aloe, each 15 parts of Fructus Cnidii, Ramulus Mori 18 parts.
The invention has the advantages that:
The plaster compatibility for the treatment of of arthritis of the present invention meets Chinese medicine " monarch " principle, scientific formula is reasonable, Drug Percutaneous Absorption, during treatment, the efficacy of a drug can be gone directly affected part, extenuate articular pain and swelling fast, there is instant effect, have no side effect, low cost and other advantages, and treatment after do not recur, not only there is satisfied short term effect, also have good late result.
Detailed description of the invention
Below in conjunction with embodiment, detailed description of the invention provided by the invention is elaborated.
embodiment 1
Radix Angelicae Pubescentis, Herba Taraxaci, geranium, Rhizoma Coptidis, Radix et Caulis Opuntiae Dillenii, each 15 parts of Cortex cercis chinensis, Herba Centipedae, Cortex Phellodendri, Bufo siccus, Rhizoma Acori Calami, Cortex Mori, each 8 parts of Rhizoma Corydalis, Rhizoma Et Radix Notopterygii, Spina Gleditsiae, Aloe, each 15 parts of Fructus Cnidii, Ramulus Mori 18 parts.
Prepared by employing traditional method, according to prescription flavour of a drug altogether fine ground end, adjusts that to mix pasty state for subsequent use with water, maltose, divide on kraft paper, cover plaster surperficial, stick during use at painful area with tissue sheet during use by prepared plaster.
embodiment 2
Radix Angelicae Pubescentis, Herba Taraxaci, geranium, Rhizoma Coptidis, Radix et Caulis Opuntiae Dillenii, each 10 parts of Cortex cercis chinensis, Herba Centipedae, Cortex Phellodendri, Bufo siccus, Rhizoma Acori Calami, Cortex Mori, each 5 parts of Rhizoma Corydalis, Rhizoma Et Radix Notopterygii, Spina Gleditsiae, Aloe, each 14 parts of Fructus Cnidii, Ramulus Mori 20 parts.
Prepared by employing traditional method, according to prescription flavour of a drug altogether fine ground end, adjusts that to mix pasty state for subsequent use with water, maltose, divide on kraft paper, cover plaster surperficial, stick during use at painful area with tissue sheet during use by prepared plaster.
embodiment 3
Radix Angelicae Pubescentis, Herba Taraxaci, geranium, Rhizoma Coptidis, Radix et Caulis Opuntiae Dillenii, each 12 parts of Cortex cercis chinensis, Herba Centipedae, Cortex Phellodendri, Bufo siccus, Rhizoma Acori Calami, Cortex Mori, each 6 parts of Rhizoma Corydalis, Rhizoma Et Radix Notopterygii, Spina Gleditsiae, Aloe, each 13 parts of Fructus Cnidii, Ramulus Mori 19 parts.
Prepared by employing traditional method, according to prescription flavour of a drug altogether fine ground end, adjusts that to mix pasty state for subsequent use with water, maltose, divide on kraft paper, cover plaster surperficial, stick during use at painful area with tissue sheet during use by prepared plaster.
embodiment 4
Radix Angelicae Pubescentis, Herba Taraxaci, geranium, Rhizoma Coptidis, Radix et Caulis Opuntiae Dillenii, each 14 parts of Cortex cercis chinensis, Herba Centipedae, Cortex Phellodendri, Bufo siccus, Rhizoma Acori Calami, Cortex Mori, each 7 parts of Rhizoma Corydalis, Rhizoma Et Radix Notopterygii, Spina Gleditsiae, Aloe, each 12 parts of Fructus Cnidii, Ramulus Mori 17 parts.
Prepared by employing traditional method, according to prescription flavour of a drug altogether fine ground end, adjusts that to mix pasty state for subsequent use with water, maltose, divide on kraft paper, cover plaster surperficial, stick during use at painful area with tissue sheet during use by prepared plaster.
embodiment 5
Radix Angelicae Pubescentis, Herba Taraxaci, geranium, Rhizoma Coptidis, Radix et Caulis Opuntiae Dillenii, each 18 parts of Cortex cercis chinensis, Herba Centipedae, Cortex Phellodendri, Bufo siccus, Rhizoma Acori Calami, Cortex Mori, each 9 parts of Rhizoma Corydalis, Rhizoma Et Radix Notopterygii, Spina Gleditsiae, Aloe, each 11 parts of Fructus Cnidii, Ramulus Mori 16 parts.
Prepared by employing traditional method, according to prescription flavour of a drug altogether fine ground end, adjusts that to mix pasty state for subsequent use with water, maltose, divide on kraft paper, cover plaster surperficial, stick during use at painful area with tissue sheet during use by prepared plaster.
embodiment 6
Radix Angelicae Pubescentis, Herba Taraxaci, geranium, Rhizoma Coptidis, Radix et Caulis Opuntiae Dillenii, each 20 parts of Cortex cercis chinensis, Herba Centipedae, Cortex Phellodendri, Bufo siccus, Rhizoma Acori Calami, Cortex Mori, each 10 parts of Rhizoma Corydalis, Rhizoma Et Radix Notopterygii, Spina Gleditsiae, Aloe, each 10 parts of Fructus Cnidii, Ramulus Mori 15 parts.
Prepared by employing traditional method, according to prescription flavour of a drug altogether fine ground end, adjusts that to mix pasty state for subsequent use with water, maltose, divide on kraft paper, cover plaster surperficial, stick during use at painful area with tissue sheet during use by prepared plaster.
embodiment 7
One, physical data
60 routine Human Osteoarthritis are divided into the plaster group (20 example) for the treatment of of arthritis of the present invention at random, and friendly clever liniment contrasts one group (20 example), and Chinese medicinal plaster contrasts two groups (20 examples), carries out randomized controlled treatment observation.
Two. inclusive criteria
1 static or movable time, the patient of pain around joint or back.
2 periarticulars have swelling or rigid patient.
3 X photodynamic diagnosis are arthritic patient.
Three, exclusion standard:
1 treatment accepted by the previous moon intra-articular injection, steroid medicine treatment or the patient that carries out operative treatment.
2 have serious having a weak heart, the patient of liver or kidney failure.(blood urea nitrogen > 70mg%, blood creatinine > 1.5mg%).
3 need due to gastroenteropathy or malnutrition the patient injecting nutritional supplementation material.
4 gestation or breast-feeding female.
5 patients having this type of drug allergy medical history.
6 use analgesic drug product with the patient for the treatment of.
Four, method
Meet above-mentioned Model Patient, be divided into the plaster group (20 example) for the treatment of of arthritis of the present invention at random, GUYOULING CHAJI matched group (20 example), Chinese medicinal plaster matched group (20 example).
The plaster group for the treatment of of arthritis of the present invention: prepare medicinal plaster with reference to the prescription described in embodiment 1 and preparation method, stick 8 hours at painful area.Every day 1 time 2 weeks is 1 course for the treatment of.Treat two courses for the treatment of.
GUYOULING CHAJI contrasts one group: GUYOULING CHAJI is applied to affected part, hot compress 20-30 minute.A 2-5 milliliter, 2--3 time on the one 2 weeks is a course for the treatment of.Treat two courses for the treatment of.
Chinese medicinal plaster contrasts two groups: Radix Angelicae Pubescentis, Herba Taraxaci, geranium, Rhizoma Et Radix Notopterygii, each 15 parts of Spina Gleditsiae, Herba Centipedae, Cortex Phellodendri, each 8 parts of Bufo siccus, each 18 parts of Rhizoma Chuanxiong, Herba speranskiae tuberculatae, Rhizoma Drynariae, Flos Carthami, Caulis Spatholobi.Prepare medicinal plaster according to the method described in embodiment 1, stick 8 hours at painful area.Every day 1 time 2 weeks is 1 course for the treatment of.Treat two courses for the treatment of.
Five, observation of curative effect
(1) arthralgia during rest, by following 4 grades of evaluations.0 grade: without pain; 1 grade: whether no matter mild pain, pain continue, can stand, not affect sleep; 2 grades: moderate or intermittent pain, pain generally seldom continue, but painful during outbreak, impact sleep; 3 grades: severe pain or day and night rest pain, and be difficult to stand, often affect sleep.
(2) the stiff persistent period in morning, by minute in units of calculate.
(3) articular pain is by following level Four calibration registration affected joints tenderness rank, is finally added and draws articular pain index.0 degree: without pain without tenderness, weight or when making maximum passive activity; 1 degree: mild pain, weight patient claims there is pain at joint margins or when touching ligament, but passive activity is not limited; 2 degree: moderate pain, weight patient claims to have pain and frowns discomfort, and activity is slightly limited; 3 degree: severe pain, weight patient claims to have pain and shrinks back, passive activity critical constraints.
(4) arthroncus, registers the swelling rank of affected joints one by one by following standard, be finally added and draw swelling index.0 grade: without swelling; 1 grade: soft tissue swelling (i.e. synovial membrane swelling, without obvious hydrarthrosis); 2 grades: on the basis of 1 grade, with hydrarthrosis.
(5) joint motion is limited, the classification of osteoarthritis function of joint.I level: movable normal; II level: range of activity is less by 30 ~ 50% than normally; III level: range of activity is less by more than 50% than normally; IV level: function of joint serious hindrance, range of activity are less by more than 70% than normally, even ankylosis.
(6) X line sheet sign, the classification of osteoarthritis X line sign.I level: joint space is normal, local joint has little hyperosteogeny to be formed as seen; II level: joint space narrows, hyperosteogeny around local joint; III level: joint space extremely narrows or joint line disappears, under articular cartilage, cystic is destroyed or the wearing and tearing of degree of taking a favourable turn bone; IV level: joint line disappears, the above bone wearing and tearing of moderate, subluxation of joint.
(7) untoward reaction: time that untoward reaction occurs, persistent period, degree and the relation with trial drug should be noted.
Untoward reaction degree: 0 grade=without uncomfortable; 1 grade=slightly uncomfortable; 2 grades=moderate is uncomfortable; 3 grades=severe is uncomfortable; 4 grades=threat to life.With the relation of trial drug: 0=irrelevant; 1=may be relevant; 2=relevant.
(8) laboratory index:
Blood, routine urinalysis, fecal occult blood testing, look into weekly once.Liver function, renal function (BUN, creatinine), treatment before and after look.
(9) X ray examination: treatment before and after look.
Efficacy assessment standard: this standard is formulated with reference to " new Chinese medicine guideline of clinical investigations ", score value × 100% before clinical symptoms integrated value improvement rate=(before treatment the rear symptom integral value of symptom integral value-treatment)/treatment.
Six, efficacy assessment standard:
(1) invalid: clinical symptoms and sign are improved less than 30%.
(2) effective: clinical symptoms and sign improve about 50%.
(3) effective: clinical symptoms and sign improve about 80%.
(4) cure: clinical symptoms and sign disappear substantially.
(5) recur: be significantly improved after treatment, but repeat symptom again after drug withdrawal.
Seven, statistical procedures:
Total data adopts SPSS 13.0 statistics software to carry out statistical analysis, and measurement data mean ± standard deviation (x ± s) represents.Before and after two groups of subject, symptom score more all adopts t to check.
Eight, result of the test:
Through two course of therapy, the assessment that Osteoarthritis therapeutic effect treatment group and each clinical parameter of two treatment of control group, disease change and comparitive study see the following form respectively.
Before and after table 1 three groups of patient treatments, articular pain index compares
| Group | n | Before treatment | After treatment |
| Of the present invention group | 20 | 2.13±0.34 | 0.63±0.35*# |
| Contrast one group | 20 | 2.21±0.85 | 1.52±0.86 |
| Contrast two groups | 20 | 2.17±0.87 | 1.63±0.68 |
Note: with contrast one group and compare, * P < 0.05; With contrast two groups and compare, #P < 0.05.
Before and after table 2 three groups of patient treatments, joint swelling index compares
| Group | n | Before treatment | After treatment |
| Of the present invention group | 20 | 2.28±1.01 | 0.75±0.22*# |
| Contrast one group | 20 | 2.12±0.58 | 1.41±0.43 |
| Contrast two groups | 20 | 2.20±1.02 | 1.40±0.32 |
Note: with contrast one group and compare, * P < 0.05; With contrast two groups and compare, #P < 0.05.
Total effects evaluation after table 3 three groups of Osteoarthritis treatments
| Group | Number of cases | Cure | Effective | Effectively | Invalid | Recurrence | Total effective rate |
| Treatment group | 20 | 7 | 8 | 3 | 2 | 0 | 90% |
| Contrast one group | 20 | 5 | 6 | 4 | 2 | 3 | 75% |
| Contrast two groups | 20 | 4 | 8 | 3 | 3 | 2 | 75% |
The above results shows, the plaster treatment group for the treatment of of arthritis of the present invention improves articular pain and arthroncus, and general curative effect is all significantly better than contrast one group and contrast two groups (P < 0.05), and difference has statistical significance.The plaster scientific formula for the treatment of of arthritis of the present invention is reasonable, Drug Percutaneous Absorption, during treatment, the efficacy of a drug can be gone directly affected part, extenuate articular pain and swelling fast, there is instant effect, have no side effect, low cost and other advantages, and do not recur after treatment, not only there is satisfied short term effect, also have good late result.
Claims (3)
1. the application of Chinese medicine preparation in the plaster of preparation treatment of arthritis, it is characterized in that, described Chinese medicine preparation is made up of the crude drug of following weight portion: Radix Angelicae Pubescentis, Herba Taraxaci, geranium, Rhizoma Coptidis, Radix et Caulis Opuntiae Dillenii, each 10-20 part of Cortex cercis chinensis, Herba Centipedae, Cortex Phellodendri, Bufo siccus, Rhizoma Acori Calami, Cortex Mori, each part of Rhizoma Corydalis 5-10, Rhizoma Et Radix Notopterygii, Spina Gleditsiae, Aloe, each 10-15 part of Fructus Cnidii, Ramulus Mori 15-20 part.
2. application according to claim 1, it is characterized in that, described Chinese medicine preparation is made up of the crude drug of following weight portion: Radix Angelicae Pubescentis, Herba Taraxaci, geranium, Rhizoma Coptidis, Radix et Caulis Opuntiae Dillenii, each 14-16 part of Cortex cercis chinensis, Herba Centipedae, Cortex Phellodendri, Bufo siccus, Rhizoma Acori Calami, Cortex Mori, each 7-9 part of Rhizoma Corydalis, Rhizoma Et Radix Notopterygii, Spina Gleditsiae, Aloe, each 13-16 part of Fructus Cnidii, Ramulus Mori 16-19 part.
3. application according to claim 1, it is characterized in that, described Chinese medicine preparation is made up of the crude drug of following weight portion: Radix Angelicae Pubescentis, Herba Taraxaci, geranium, Rhizoma Coptidis, Radix et Caulis Opuntiae Dillenii, each 15 parts of Cortex cercis chinensis, Herba Centipedae, Cortex Phellodendri, Bufo siccus, Rhizoma Acori Calami, Cortex Mori, each 8 parts of Rhizoma Corydalis, Rhizoma Et Radix Notopterygii, Spina Gleditsiae, Aloe, each 15 parts of Fructus Cnidii, Ramulus Mori 18 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510265933.8A CN104887909A (en) | 2015-05-24 | 2015-05-24 | Application of external-application traditional Chinese medicine for treating arthritis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510265933.8A CN104887909A (en) | 2015-05-24 | 2015-05-24 | Application of external-application traditional Chinese medicine for treating arthritis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104887909A true CN104887909A (en) | 2015-09-09 |
Family
ID=54021151
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510265933.8A Pending CN104887909A (en) | 2015-05-24 | 2015-05-24 | Application of external-application traditional Chinese medicine for treating arthritis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104887909A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101062152A (en) * | 2007-05-29 | 2007-10-31 | 沈信堂 | Chinese medicine for treating rheumatoid arthritis |
| CN101361888A (en) * | 2008-09-18 | 2009-02-11 | 李爱英 | Traditional Chinese medicine for treating rheumatism and rheumatoid |
| CN101816713A (en) * | 2010-04-02 | 2010-09-01 | 河南妙正医药有限公司 | Garden balsam stem pain-relieving paste |
| CN104352811A (en) * | 2014-10-28 | 2015-02-18 | 青岛市市立医院 | Plaster for curing bone injury and preparation method thereof |
-
2015
- 2015-05-24 CN CN201510265933.8A patent/CN104887909A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101062152A (en) * | 2007-05-29 | 2007-10-31 | 沈信堂 | Chinese medicine for treating rheumatoid arthritis |
| CN101361888A (en) * | 2008-09-18 | 2009-02-11 | 李爱英 | Traditional Chinese medicine for treating rheumatism and rheumatoid |
| CN101816713A (en) * | 2010-04-02 | 2010-09-01 | 河南妙正医药有限公司 | Garden balsam stem pain-relieving paste |
| CN104352811A (en) * | 2014-10-28 | 2015-02-18 | 青岛市市立医院 | Plaster for curing bone injury and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103230488B (en) | Traditional Chinese medicine composition for treating lumbar disc herniation, osteoproliferation and cervical spondylosis | |
| CN103169805A (en) | Medicament for treating meniscus injury | |
| CN103405742B (en) | Drug composition for treating infantile diarrhea and preparation method thereof | |
| CN102552713A (en) | Medicine for treating epilepsy and preparation method thereof | |
| CN107669991A (en) | A kind of pharmaceutical composition for reducing serum uric acid level and preparation method thereof | |
| CN102423444B (en) | Traditional Chinese medicine preparation for treating rheumatism and internal lesion caused by overexertion and preparation method thereof | |
| CN103565969A (en) | Traditional Chinese medicine composition for treating soft tissue injury and fracture | |
| CN103638456B (en) | A kind of Chinese medicine for the treatment of liver cirrhosis and preparation method thereof | |
| CN103908600B (en) | The external used medicine for the treatment of rheumatoid arthritis damp-heat arthralgia resistance card and preparation method | |
| CN104887909A (en) | Application of external-application traditional Chinese medicine for treating arthritis | |
| CN104887868A (en) | Plaster for treating arthritis | |
| CN104887869A (en) | Plaster for treating osteoarthritis | |
| CN104906325A (en) | Purpose of Chinese herba preparation in treating osteoarthritis | |
| CN101647980B (en) | Traditional Chinese medicine paste for expelling wind, removing dampness and promoting blood circulation to stop pain | |
| CN104548048A (en) | Traditional Chinese medicine composition for treating rheumatic tendon and bone diseases | |
| CN104547589A (en) | Traditional Chinese medicine for treating polymyalgia rheumatica and applications of traditional Chinese medicine | |
| CN109939212A (en) | A kind of Chinese materia medica preparation that treating axillary nerve injury and preparation method | |
| CN104225016A (en) | Drug composition for treating spleen and stomach deficiency type chronic atrophic gastritis | |
| CN103768290A (en) | Traditional Chinese medicine composition for treating synovitis and preparation method thereof | |
| CN104491297B (en) | A kind of Chinese medicine composition for treating palindromic urinary tract infection | |
| CN103301368A (en) | Medicament for treating hyperactivity | |
| CN102764325B (en) | Chinese medicinal composition for dispelling rheumatism and relieving pain | |
| CN103623242B (en) | Medicament for treating hyperlipemia on inspection | |
| CN103845690A (en) | Medicament for treating geriatric depression | |
| CN103239525B (en) | Blood activating and lipid lowering medicinal liquor and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150909 |
|
| RJ01 | Rejection of invention patent application after publication |